MICHEAL HENKE: Open Payments
NPI 1144767385 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,426 in 91 payments from 21 companies in 2025. Trend: 2023 $1,472 · 2024 $1,817 · 2025 $1,426
Food & beverage: $1,426
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $283 |
| Amgen Inc. | 12 | $170 |
| PFIZER INC. | 14 | $170 |
| AstraZeneca Pharmaceuticals LP | 4 | $138 |
| Lilly USA, LLC | 10 | $130 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $122 |
| Novo Nordisk Inc | 4 | $62 |
| Madrigal Pharmaceuticals | 2 | $61 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
Products named: VRAYLAR, FARXIGA, JARDIANCE, NURTEC ODT, MOUNJARO, EVENITY, QULIPTA, REZDIFFRA.
Industry payments across ND — which companies pay providers there.
